Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells - Newling - 2018 - European Journal of Immunology - Wiley Online Library
Por um escritor misterioso
Descrição
Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis, Stem Cell Research & Therapy
Frontiers Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination
Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells - Newling - 2018 - European Journal of Immunology - Wiley Online Library
Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis, Stem Cell Research & Therapy
Metastatic Colon Cancer Treatment Using S100A9-Targeted Cowpea Mosaic Virus Nanoparticles
WO2018187613A2 - Anti-icos agonist antibodies and uses thereof - Google Patents
MSC-mediated immunosuppression. In the presence of high levels of IFN-γ
Structure–Function Analysis of Immune Checkpoint Receptors to Guide Emerging Anticancer Immunotherapy
Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker
PDF) Are Fc Gamma Receptor Polymorphisms Important in HIV-1 Infection Outcomes and Latent Reservoir Size?
Immunological analysis of the murine anti‐CD3‐induced cytokine release syndrome model and therapeutic efficacy of anti‐cytokine antibodies - Nouveau - 2021 - European Journal of Immunology - Wiley Online Library
de
por adulto (o preço varia de acordo com o tamanho do grupo)
